Blue Fin Capital Inc.'s holdings in CVS Health were worth $1,331,000 as of its most recent SEC filing. Patten Group Inc. now owns 1,844 shares of the pharmacy operator's stock valued at $145,000 after purchasing an additional 1,144 shares during the last quarter. The original version of this piece can be viewed at https://pressoracle.com/news/2019/01/18/cvs-health-corp-cvs-stake-lifted-by-stock-yards-bank-trust-co.html. The institutional investor owned 371,405 shares of the pharmacy operator's stock after acquiring an additional 1,952 shares during the quarter. CVS Health had 6 analyst reports since September 17, 2018 according to SRatingsIntel. Argus boosted their price objective on shares of CVS Health to $100.00 and gave the company a "buy" rating in a report on Tuesday, November 13th.
At time of publication, Walmart traded up marginally at $97.40, while CVS traded up 2.5 percent at $64.95. One analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the company.
CVS Health Corporation registered $18.41 million net activity with 0 insider buys and 7 insider sales since August 27, 2018. On Wednesday, November 14 a trade for 14,229 shs valued at $1.17 million was made by Brennan Troyen A. Another trade for 8,564 shs valued at $642,300 was made by Hourican Kevin on Monday, August 27. The stock was sold at an average price of $82.00, for a total value of $1,166,778.00. On Thursday, November 29 the firm has "Hold" rating given by Goldman Sachs.
Sudan doctors vow continued protests after colleague killed at close range
The government's tough response has sparked global criticism, while Bashir has blamed the violence on unidentified "conspirators". According to government statistics, at least 26 people have been killed during the protests.
A frequently relied-upon technique for evaluating any given stock's value at a particular point is by viewing its current price in relation to its 52-week range.
More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Benzinga.com which released: "Raymond James: CVS (NYSE:CVS) A Strong Buy Despite Pricing Headwinds - Benzinga" on January 15, 2019, also Seekingalpha.com with their article: "Walmart to exit CVS drugstore network - Seeking Alpha" published on January 15, 2019, Seekingalpha.com published: "Molina renews PBM contract with CVS Caremark - Seeking Alpha" on January 03, 2019. The disclosure for this sale can be found here. Palo Capital Inc. now owns 39,308 shares of the pharmacy operator's stock worth $3,094,000 after buying an additional 7,527 shares during the last quarter. Compton Incorporated Ri invested in 28,631 shares or 0.89% of the stock. Heritage Invsts Corp stated it has 0.02% in CVS Health Corporation (NYSE:CVS). The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94. The stock has a market cap of $65.12 billion, a PE ratio of 11.02, a price-to-earnings-growth ratio of 0.78 and a beta of 1.12. $1.03M worth of CVS Health Corporation (NYSE:CVS) was sold by Boratto Eva C. Denton David M also sold $2.02 million worth of CVS Health Corporation (NYSE:CVS) on Thursday, November 29. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.71 by $0.02. That's up 11.46 % from last year's $1.92 EPS. The business's quarterly revenue was up 2.4% on a year-over-year basis. Investors of record on Friday, January 25th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 3.13%. The ex-dividend date of this dividend is Thursday, January 24th. Essex Investment Management Lc stated it has 0.19% in CVS Health Corporation (NYSE:CVS).